gene therapy - search results

Dr Stefano Savonitto, Director of Cardiology at Manzoni Hospital sheds light on the risk of heart disease in women  When thinking about their health, women are especially concerned about cancer. However, the most frequent cause of death among women is heart disease and especially coronary artery disease. The number of...

Owen Sharp, CEO at Prostate Cancer UK sheds light on the important work that’s being done to better diagnose and treat prostate cancer Most prostate cancers aren’t a problem. In fact, for many, the problems only come from diagnosing and treating them. These are the prostate cancers a surgeon once...

Hepatocellular carcinoma (HCC) reflects the most common primary liver cancer as well as the 2nd most common cause of cancer related death in humans worldwide. In most cases HCC is caused by chronic liver damage that is either induced by chronic viral infections (e.g. Hepatitis B or C viruses),...

Alexandra Bishop, Tissue Viability Nurse Specialist at Plymouth Wound Care discusses how effective wound care can make all the difference to a patient, and the NHS… The importance of effective wound care cannot be underestimated. Wounds in complex patients and those that are poorly managed can lead to the development of...

Jon Pleat MA DPhil FRCS(Plast), Plastic Surgeon and Scientific Advisor at SCaRF details the risks of skin cancer and how it can be prevented… Skin cancer is the most common form of cancer globally. There are more than 80,000 deaths a year from its different forms. Within the UK, the incidence...

Alexandra Bishop, Tissue Viability Nurse Specialist at Plymouth Wound Care discusses how effective wound care can make all the difference to a patient, and the NHS The importance of effective wound care cannot be underestimated. Wounds in complex patients and those that are poorly managed can lead to the development of...

Jon Pleat MA DPhil FRCS(Plast), Plastic Surgeon and Scientific Advisor at SCaRF details the risks of skin cancer and how it can be prevented Skin cancer is the most common form of cancer globally. There are more than 80,000 deaths a year from its different forms. Within the UK, the incidence...

Luminex xTAG® CYP2D6 Kit v3 and xTAG® CYP2C19 Kit v3 assays may aid in determining therapeutic strategies for drugs metabolized by CYP2D6 and CYP2C19 gene products Physicians have long been aware of the subtle differences between patients and their responses to medications. The recognition that a part of this variation...

Energy defects, neuroinflammatory processes, and abnormal cellular morphology in neurodegenerative diseases (ND) would constitute extremely informative brain imaging biomarkers of disease progression and readouts in clinical trials. Emerging research aims at developing novel brain imaging methods to study these different aspects not only in animal models but also in...

Physicians have long been aware of the subtle differences between patients and their responses to medications. The recognition that a part of this variation is inherited, and therefore predictable, created the field of pharmacogenetics several years ago. Pharmacogenetics studies the influence of genetic variation on drug response. Genetic variation is...

AG spoke to Dr Arturo Chiti, President Elect of the European Association for Nuclear Medicine (EANM) about the role nuclear medicine plays in modern society, and its challenges. In modern society there are a number of healthcare challenges that researchers are fighting against to find new prevention methods and treatments...

Daniel Bridge, Policy Manager at Cancer Research UK gives consideration to how science has contributed significantly to cancer research. Medical research provides the foundation of modern medicine; it is vital to tackling the health challenges of the future. We know this because of the remarkable results research has produced to...

Professor Alan Clarke, Director of the European Cancer Stem Cell Research Institute at Cardiff University, outlines the aim to develop more personalised therapies for patients with cancer and how targeting the cancer stem cell could be crucial in this development. Cancer remains the second largest cause of death in the western...

Viscofan BioEngineering combines natural sciences and engineering to provide innovative bioproducts as new solutions for cell biology, tissue engineering and regenerative medicine. Viscofan BioEngineering is a business unit within the food industry Viscofan (MCE:VIS) which has its headquarters in Spain and an annual turnover of €800M. Our main operations...

Professor Jamie Hacker Hughes, Military Psychologist, and Director at the Veterans and Families Institute, Anglia Ruskin University, highlights the importance of our armed forces being in excellent mental health. The mental fitness of Britain’s Armed Forces is every bit as important as the physical fitness for which they are rightly...

Adnan Sharif, Consultant Nephrologist at University Hospitals Birmingham discusses kidney transplants and the impact it has on the patient and their quality of life. Chronic kidney disease affects over 10% of the UK population and can progress to end-.stage kidney disease, requiring renal replacement therapy in the form of either...

Cancer Research UK have today launched a new Lung Cancer Centre of Excellence that will bring together leading researchers from The University of Manchester and London. Cancer Research UK announced that a new centre to tackle lung cancer will open today in Manchester. The centre will be dedicated to the research...

Claire Bale, Communications Manager for Parkinson’s UK, highlights the latest thinking in stem cell research for the potential treatment of Parkinson’s. Stem cells can develop into almost any cell in the body. They are the original cells from which we are made, and are responsible for repairing our tissues and...

Professor Alan Clarke, Director of the European Cancer Stem Cell Research Institute gives an overview of how cancer stem cells differ from the conventional stem cell. Cancer remains one of the major challenges in terms of life expectancy and is recognised as the second largest cause of mortality within the...

Professor Alan Clarke, Director of the European Cancer Stem Cell Research Institute gives an overview of how cancer stem cells differ from the conventional stem cell. Cancer remains one of the major challenges in terms of life expectancy and is recognised as the second largest cause of mortality within the...